CHF Solutions (NSDQ:CHFS) said it has finished transferring all manufacturing for the Aquadex FlexFlow fluid filtration system to its Eden Prairie, Minn. plant.
CHF acquired the Aquadex device in 2016 for $5 million from Baxter (NYSE:BAX), which had been the contract manufacturer of CHF products.
CHF began the manufacturing transfer in June 2017 and completed it by beginning catheter production in-house. The Aquadex system is designed to filter water and salt from patients experiencing fluid overload due to heart failure.
Get the full story from our sister site, Medical Design & Outsourcing.
The post CHF Solutions takes Aquadex manufacturing in-house appeared first on MassDevice.
from MassDevice https://ift.tt/2o2JAcL
Cap comentari:
Publica un comentari a l'entrada